In severe cases, imaging studies like CT scans are used to assess potential brain swelling or trauma
There were a lot of things happening and new people coming in
Eli Lilly is developing a next-generation GLP therapy called retatrutide that targets three receptors: GLP-1, GIP, and glucagon
Dozio E, Vianello E, Malavazos AE, Tacchini L, Schmitz G, Iacobellis G, et al
PlexusDx's $99 Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways and 150+ genetic insights, predicting your baseline responsiveness to GLP-1 therapy
At sixth prescription refill ( n = 7304), 6.2% patients were still receiving tirzepatide dose of 2.5 mg and over half of the patients were receiving tirzepatide doses of 5 mg (26.5%) or 7.5 mg (23.9%)